Global Insulin Market Research Report 2018-2028

  • Published Date : 14-12-2021
  • Pages : 104
  • Report Id : 60710
  • Categories : Healthcare

Summary
Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism.
The global Insulin market will reach xxx Million USD in 2022 with CAGR xx% 2022-2028. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Ultra-short-acting insulin
Short-acting insulin
In effect insulin
Long-acting insulin
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Novartis
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
MannKind
Sanofi
Merck
Bioton
GEA
Emisphere
Salix Pharmaceuticals
Gan & Lee
Dongbao
United Laboratories (TUL)
Takeda Pharmaceutical Company
Shihuida PHARMA Group
Henan Tian Fang Pharmaceutical
Disha Pharmaceutical Group
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Type 1 diabetes
Type 2 diabetes
Others diabetes
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa


Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Insulin Picture
1.1.2 Specifications
Table Product Specifications of Insulin
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Insulin
Table Global Insulin Market by Type, 2018-2028 (USD Million)
1.2.1.1 Ultra-short-acting insulin
Table Ultra-short-acting insulin Overview
1.2.1.2 Short-acting insulin
Table Short-acting insulin Overview
1.2.1.3 In effect insulin
Table In effect insulin Overview
1.2.1.4 Long-acting insulin
Table Long-acting insulin Overview
1.2.2 by Application
Table Application Segment of Insulin
Table Global Insulin Market by Application, 2018-2028 (USD Million)
1.2.2.1 Type 1 diabetes
Table Type 1 diabetes Overview
1.2.2.2 Type 2 diabetes
Table Type 2 diabetes Overview
1.2.2.3 Others diabetes
Table Others diabetes Overview
1.2.3 by Regions
Table Global Insulin Market by Region, 2018-2028 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Insulin
2.2 Upstream
Table Cost of Insulin
Figure Manufacturing Process of Insulin
2.3 Market
2.3.1 SWOT
Figure SWOT of Insulin
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Insulin
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Insulin
3.4 Market Entry
Table Market Entry of Insulin
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Ultra-short-acting insulin Market, 2017-2021
Figure Ultra-short-acting insulin Market Size and Growth, 2017-2021 (USD Million)
Figure Ultra-short-acting insulin Market Size and Growth, 2017-2021 (in Volume)
Table Ultra-short-acting insulin CAGR by Revenue and Volume, 2017-2021
4.1.2 Short-acting insulin Market, 2017-2021
Figure Short-acting insulin Market Size and Growth, 2017-2021 (USD Million)
Figure Short-acting insulin Market Size and Growth, 2017-2021 (in Volume)
Table Short-acting insulin CAGR by Revenue and Volume, 2017-2021
4.1.3 In effect insulin Market, 2017-2021
Figure In effect insulin Market Size and Growth, 2017-2021 (USD Million)
Figure In effect insulin Market Size and Growth, 2017-2021 (in Volume)
Table In effect insulin CAGR by Revenue and Volume, 2017-2021
4.1.4 Long-acting insulin Market, 2017-2021
Figure Long-acting insulin Market Size and Growth, 2017-2021 (USD Million)
Figure Long-acting insulin Market Size and Growth, 2017-2021 (in Volume)
Table Long-acting insulin CAGR by Revenue and Volume, 2017-2021
4.2 Market Forecast
4.2.1 Ultra-short-acting insulin Market Forecast, 2022-2028
Figure Ultra-short-acting insulin Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Ultra-short-acting insulin Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Ultra-short-acting insulin CAGR by Revenue and Volume, 2018-2028
4.2.2 Short-acting insulin Market Forecast, 2022-2028
Figure Short-acting insulin Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Short-acting insulin Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Short-acting insulin CAGR by Revenue and Volume, 2018-2028
4.2.3 In effect insulin Market Forecast, 2022-2028
Figure In effect insulin Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure In effect insulin Market Estimates and Forecasts, 2022-2028 (in Volume)
Table In effect insulin CAGR by Revenue and Volume, 2018-2028
4.2.4 Long-acting insulin Market Forecast, 2022-2028
Figure Long-acting insulin Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Long-acting insulin Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Long-acting insulin CAGR by Revenue and Volume, 2018-2028
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Type 1 diabetes Market, 2017-2021
Figure Type 1 diabetes Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Type 1 diabetes CAGR by Revenue and Volume, 2017-2021
5.1.2 Type 2 diabetes Market, 2017-2021
Figure Type 2 diabetes Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Type 2 diabetes CAGR by Revenue and Volume, 2017-2021
5.1.3 Others diabetes Market, 2017-2021
Figure Others diabetes Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Others diabetes CAGR by Revenue and Volume, 2017-2021
5.2 Market Forecast
5.2.1 Type 1 diabetes Market Forecast, 2022-2028
Figure Type 1 diabetes Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Type 1 diabetes Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Type 1 diabetes CAGR by Revenue and Volume, 2022-2028
5.2.2 Type 2 diabetes Market Forecast, 2022-2028
Figure Type 2 diabetes Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Type 2 diabetes Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Type 2 diabetes CAGR by Revenue and Volume, 2022-2028
5.2.3 Others diabetes Market Forecast, 2022-2028
Figure Others diabetes Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Others diabetes Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Others diabetes CAGR by Revenue and Volume, 2022-2028
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2017-2021
Figure Asia-Pacific Market Size and Growth, 2017-2021 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2017-2021 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2017-2021
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2017-2021
Figure North America Market Size and Growth, 2017-2021 (USD Million)
Figure North America Market Size and Growth, 2017-2021 (in Volume)
Table North America CAGR by Revenue and Volume, 2017-2021
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2017-2021
Figure Europe Market Size and Growth, 2017-2021 (USD Million)
Figure Europe Market Size and Growth, 2017-2021 (in Volume)
Table Europe CAGR by Revenue and Volume, 2017-2021
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2017-2021
Figure South America Market Size and Growth, 2017-2021 (USD Million)
Figure South America Market Size and Growth, 2017-2021 (in Volume)
Table South America CAGR by Revenue and Volume, 2017-2021
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2017-2021
Figure Middle East & Africa Market Size and Growth, 2017-2021 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2017-2021 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2017-2021
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2022-2028
Figure Asia-Pacific Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2022-2028
6.2.2 North America Market Forecast, 2022-2028
Figure North America Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure North America Market Estimates and Forecasts, 2022-2028 (in Volume)
Table North America CAGR by Revenue and Volume, 2022-2028
6.2.3 Europe Market Forecast, 2022-2028
Figure Europe Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Europe Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Europe CAGR by Revenue and Volume, 2022-2028
6.2.4 South America Market Forecast, 2022-2028
Figure South America Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure South America Market Estimates and Forecasts, 2022-2028 (in Volume)
Table South America CAGR by Revenue and Volume, 2022-2028
6.2.5 Middle East & Africa Market Forecast, 2022-2028
Figure Middle East & Africa Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2022-2028
7 Market Competitive
7.1 Global Market by Vendors
Table Global Insulin Market by Vendors, 2017-2021 (in Volume)
Table Global Insulin Market Share by Vendors, 2017-2021 (USD Million)
Table Global Insulin Market Share by Vendors, 2017-2021 (in Volume)
7.2 Market Concentration
Figure Insulin Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Novartis
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Novo Nordisk
Table Novo Nordisk Profile List
Table Microecological Modulator Operating Data of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Boehringer Ingelheim
Table Boehringer Ingelheim Profile List
Table Microecological Modulator Operating Data of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Bristol-Myers Squibb
Table Bristol-Myers Squibb Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Eli Lilly
Table Eli Lilly Profile List
Table Microecological Modulator Operating Data of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 MannKind
Table MannKind Profile List
Table Microecological Modulator Operating Data of MannKind (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Sanofi
Table Sanofi Profile List
Table Microecological Modulator Operating Data of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Merck
Table Merck Profile List
Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Bioton
Table Bioton Profile List
Table Microecological Modulator Operating Data of Bioton (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 GEA
Table GEA Profile List
Table Microecological Modulator Operating Data of GEA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Emisphere
Table Emisphere Profile List
Table Microecological Modulator Operating Data of Emisphere (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Salix Pharmaceuticals
Table Salix Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Salix Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Gan & Lee
Table Gan & Lee Profile List
Table Microecological Modulator Operating Data of Gan & Lee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Dongbao
Table Dongbao Profile List
Table Microecological Modulator Operating Data of Dongbao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 United Laboratories (TUL)
Table United Laboratories (TUL) Profile List
Table Microecological Modulator Operating Data of United Laboratories (TUL) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 Takeda Pharmaceutical Company
Table Takeda Pharmaceutical Company Profile List
Table Microecological Modulator Operating Data of Takeda Pharmaceutical Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.17 Shihuida PHARMA Group
Table Shihuida PHARMA Group Profile List
Table Microecological Modulator Operating Data of Shihuida PHARMA Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.18 Henan Tian Fang Pharmaceutical
Table Henan Tian Fang Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Henan Tian Fang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.19 Disha Pharmaceutical Group
Table Disha Pharmaceutical Group Profile List
Table Microecological Modulator Operating Data of Disha Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Research Allied Copyright © 2022 .